Christa Walgaard

Capelle Aan Den Ijssel, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

If it does not help, it might hurt: Pharmacodynamics of a second IVIg course in Guillain-Barré syndrome.

If it does not help, it might hurt: Pharmacodynamics of a second IVIg course in Guillain-Barré syndrome.

Journal: Annals of clinical and translational neurology

Published: December 24, 2024

Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.

Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.

Journal: EBioMedicine

Published: August 22, 2023

High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.

High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 10, 2022

Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome.

Modified Erasmus GBS Respiratory Insufficiency Score: a simplified clinical tool to predict the risk of mechanical ventilation in Guillain-Barré syndrome.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: July 06, 2022

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.

Journal: Brain : a journal of neurology

Published: April 23, 2021

International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score.

International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score.

Journal: Annals of neurology

Published: March 01, 2021

Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.

Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.

Journal: Neurology

Published: February 10, 2021

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.

Journal: The Lancet. Neurology

Published: June 19, 2020

IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.

IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.

Journal: Annals of clinical and translational neurology

Published: August 15, 2018

Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.

Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.

Journal: Journal of the peripheral nervous system : JPNS

Published: August 01, 2018

Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barré syndrome.

Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barré syndrome.

Journal: PloS one

Published: January 03, 2018

Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.

Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.

Journal: JAMA neurology

Published: December 28, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026